Posts Tagged: COVID-19
Examining the USPTO’s Patents 4 Partnerships Platform
Intellectual property (IP) is a “bridge to collaboration” between companies, and not just a “weapon of competitive warfare.” The U.S. Patent and Trademark Office (USPTO) launched …
WHO’s C-TAP Initiative Pushes for Non-Exclusive Global Licensing Amid Pharma Industry Concerns
On Friday, May 29, the World Health Organization (WHO) officially launched the COVID-19 Technology Access Pool (C-TAP), an initiative which is intended to improve access to treatments, vaccines …
Business (Almost) as Usual at Brazilian IP Courts and IPO
Like most countries, Brazil has been facing severe restrictions in an attempt to slow down the spread of COVID-19. Non-essential services are currently closed in almost all …
International Approaches to Accelerating Innovation and Access in the Pandemic
In the wake of COVID-19, government officials around the world face unprecedented decisions about when and to what extent they should reopen their respective societies before effective …
Patent Rights and Wrongs in the COVID-19 Pandemic: EU and U.S. Approaches to Compulsory Licensing
As governments around the globe fight the COVID-19 outbreak, pharmaceutical companies race to develop a vaccine and potentially secure a patent for it. To speed the process, …
Four Artificial Intelligence Technologies to Lead the Global Economy Out of the Pandemic
Technology innovation in artificial intelligence (AI) is accelerating at a breakneck pace, and the ability to innovate, adopt and integrate AI techniques to evolve business models will …
USPTO COVID-19 Pilot Program Will Benefit Small Companies and Individual Inventors
On May 7, the U.S. Patent and Trademark Office (USPTO) published a Notice in the Federal Register regarding the implementation of a new pilot program for COVID-19 …
Practice at the Patent Trial and Appeal Board During a Pandemic
The business of the Patent Trial and Appeal Board (PTAB) continues on as most practitioners transition into another month of working from home. Like many courts, the …
Conservative Leaders Rebut Proposed Denial of Exclusivity on COVID Meds
More than 30 leading conservative and libertarian organizations have joined on a letter to Congress, voicing “strong opposition” to principles, recently unveiled by four senior lawmakers, that would …
Stand Up to the Anti-Patent COVID-19 Narrative
It may seem odd, as unprecedented public/private sector R&D alliances work to discover and develop therapies to counter COVID-19, that some are trying to punish …
USPTO Further Extends Certain Patent and Trademark Deadlines in Accordance with the CARES Act
On April 28, the United States Patent and Trademark Office (USPTO) issued official Patent and Trademark notices announcing that it will be further extending certain patent and trademark …
Suing for Patent Infringement if the Government Takes Your Intellectual Property During the COVID-19 Pandemic
As COVID-19 continues to rapidly sweep the globe, government agencies at all levels are taking measures to curb the spread of the virus. Private companies have announced …
Examining Antitrust Guidance on Cooperation in Fighting COVID-19
The novel coronavirus pandemic has upended our lives, creating a far-from-normal “new normal.” And it has also given rise to countless collaborations between and among universities, hospitals, …
Don’t Let Life Sciences Innovation Become Another Coronavirus Casualty
With two-thirds of the world in lockdown and no clear way out of the novel coronavirus crisis, it’s increasingly obvious that biopharmaceutical innovation will play a …
3M Targets N95 Respirator Company’s Alleged Price-Gouging Scheme via Trademark Infringement Suit
On April 10, multinational corporation 3M filed a lawsuit alleging trademark infringement claims against N95 respirator distributor Performance Supply, LLC, in the Southern District of New York. Central …
